India Globalization Capital Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IGC | TAK | ZTS | GRFS | NBIX |
| Company | India Globalization Capital Inc | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Grifols S.A. ADR | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.4626 | 13.32 | 149.25 | 6.42 | 140.89 |
| High | 0.4688 | 13.33 | 151.74 | 6.44 | 144.70 |
| Low | 0.4130 | 13.21 | 148.75 | 6.29 | 138.01 |
| Last | 0.4228 | 13.26 | 151.04 | 6.32 | 139.21 |
| Change | -0.0338 | -0.12 | +1.48 | -0.16 | -0.88 |
| % Change | -7.40% | -0.90% | +0.99% | -2.47% | -0.63% |
| Volume | 372,669 | 532,816 | 2,269,681 | 572,018 | 468,889 |
| 20-Day Average Volume | 1,691,351 | 1,742,104 | 4,029,219 | 1,337,185 | 789,310 |
| Previous Close | 0.4566 | 13.38 | 149.56 | 6.48 | 140.09 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5149 | 13.49 | 158.68 | 6.70 | 136.58 |
| 20-Day Raw Stochastic | 9.33% | 12.30% | 24.51% | 5.45% | 62.14% |
| 20-Day Relative Strength | 48.50% | 37.04% | 34.89% | 42.98% | 54.74% |
| Weighted Alpha | +3.32 | -20.37 | -19.77 | -4.01 | +40.22 |
| Today's Opinion | 88% Buy | 100% Sell | 88% Sell | 100% Sell | 96% Buy |
| Previous Opinion | 88% Buy | 100% Sell | 88% Sell | 100% Sell | 96% Buy |
| Last Month's Opinion | 56% Buy | 72% Sell | 40% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -27.54% since 04/17/24 | +0.87% since 04/17/24 | -0.45% since 04/17/24 | -4.10% since 04/17/24 | +4.61% since 04/17/24 |
| Low | 0.4130 on 04/24/24 | 13.12 on 04/18/24 | 144.80 on 04/22/24 | 6.25 on 04/22/24 | 130.13 on 04/19/24 |
| High | 0.5700 on 04/18/24 | 13.41 on 04/23/24 | 153.67 on 04/18/24 | 6.66 on 04/23/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | +13.03% since 03/22/24 | -7.95% since 03/22/24 | -10.45% since 03/22/24 | +1.45% since 03/22/24 | -1.46% since 03/22/24 |
| Low | 0.3530 on 03/26/24 | 13.11 on 04/17/24 | 144.80 on 04/22/24 | 6.25 on 04/22/24 | 130.13 on 04/19/24 |
| High | 0.9099 on 04/04/24 | 14.45 on 03/26/24 | 171.14 on 03/28/24 | 7.35 on 04/09/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +51.84% since 01/24/24 | -9.64% since 01/24/24 | -18.71% since 01/24/24 | -17.62% since 01/24/24 | -0.53% since 01/24/24 |
| Low | 0.2700 on 02/22/24 | 13.11 on 04/17/24 | 144.80 on 04/22/24 | 5.30 on 03/06/24 | 128.00 on 02/07/24 |
| High | 0.9099 on 04/04/24 | 14.88 on 02/27/24 | 200.53 on 02/29/24 | 9.37 on 02/28/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +34.92% since 10/24/23 | -9.02% since 10/24/23 | -9.49% since 10/24/23 | -21.91% since 10/24/23 | +27.57% since 10/24/23 |
| Low | 0.2501 on 12/20/23 | 13.11 on 04/17/24 | 144.80 on 04/22/24 | 5.30 on 03/06/24 | 103.63 on 11/10/23 |
| High | 0.9099 on 04/04/24 | 15.07 on 01/12/24 | 201.92 on 12/14/23 | 12.15 on 12/29/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,507 | 42,345,264 | 68,402,608 | 4,455,389 | 13,939,936 |
| Shares Outstanding, K | 66,813 | 3,164,818 | 457,359 | 687,560 | 99,507 |
| Annual Sales | 910,000 | 29,803,340,000 | 8,544,000,000 | 7,134,500,000 | 1,887,100,000 |
| Annual Net Income | -11,510,000 | 2,345,930,000 | 2,344,000,000 | 131,340,000 | 249,700,000 |
| Last Quarter Sales | 200,000 | 7,556,070,000 | 2,213,000,000 | 2,025,030,000 | 515,200,000 |
| Last Quarter Net Income | -5,590,000 | 718,900,000 | 525,000,000 | 125,920,000 | 147,700,000 |
| 60-Month Beta | 1.71 | 0.53 | 0.85 | 0.56 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 02/14/24 | 0.51 on 02/01/24 | 1.24 on 02/13/24 | 0.09 on 07/27/23 | 1.44 on 02/07/24 |
| Latest Earnings Date | 02/13/24 | 05/09/24 | 05/02/24 | 03/05/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.261 on 09/28/23 | 0.432 on 04/18/24 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 09/28/23 | 04/18/24 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.85 | 27.36 | 0.00 | 55.23 |